These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894 [No Abstract] [Full Text] [Related]
46. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes. Andersen OO Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008 [No Abstract] [Full Text] [Related]
47. [Insulin resistance and insulin antibodies]. Bemm H Dtsch Z Verdau Stoffwechselkr; 1967 Nov; 27(3):61-8. PubMed ID: 5595731 [No Abstract] [Full Text] [Related]
48. [Changes of carbohydrate metabolism in normal pregnancy and its relationship with placental lactogen concentrations]. Cao X; Qin W; He Z Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):80-2. PubMed ID: 10682424 [TBL] [Abstract][Full Text] [Related]
49. The rationale for the use of drugs in the treatment of diabetes mellitus. Kryston LJ; Shaw RA Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077 [No Abstract] [Full Text] [Related]
50. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics. Lev-Ran AS Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820 [No Abstract] [Full Text] [Related]
52. [Use of an artificial beta-cell (Biostator) in clinical practice]. Andreev D; Arnaudov I; Veleva N; Todorova S Vutr Boles; 1980; 19(6):60-6. PubMed ID: 6782760 [No Abstract] [Full Text] [Related]
53. Medical grand rounds from the West Virginia University Hospital. Insulin resistance. Jones DL W V Med J; 1979 Sep; 75(9):264-70. PubMed ID: 384675 [No Abstract] [Full Text] [Related]
54. Insulin degradation in serum of a patient with apparent insulin resistance. Misbin RI; Almira EC; Cleman MW J Clin Endocrinol Metab; 1981 Feb; 52(2):177-80. PubMed ID: 7007401 [TBL] [Abstract][Full Text] [Related]
55. [What is the responsibility of the anti-insulin antibodies in resistant diabetes?]. Rosselin G; Bricaire H; Dérot M; Hamburger J; Péquignot H Presse Med (1893); 1968 Feb; 76(10):463-6. PubMed ID: 4170692 [No Abstract] [Full Text] [Related]
56. Insulin-antagonistic effects of counterregulatory hormones: clinical and mechanistic aspects. Smith U; Lager I Diabetes Metab Rev; 1989 Sep; 5(6):511-25. PubMed ID: 2670491 [No Abstract] [Full Text] [Related]
57. Serum insulin and anti-insulin activity in diabetic acidosis. WILLEBRANDS AF Clin Chim Acta; 1960 Jul; 5():508-19. PubMed ID: 13844797 [No Abstract] [Full Text] [Related]
58. Relation between antibody and insulin dose. Devlin JG; Brien T; Stephenson N Br Med J; 1967 Mar; 1(5539):542-4. PubMed ID: 6017157 [No Abstract] [Full Text] [Related]